Please assess the completion status of the following clinical trial:

Trial Title: Clinical Investigation of an AcrySof IQ PanOptix Toric Intraocular Lens

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Key Inclusion Criteria:~* Eligible to be implanted with AcrySof IQ PanOptix Toric Intraocular Lens Model TFNT20 in at least one eye.~* Potential postoperative Best Corrected Distance Visual Acuity (BCDVA) of 0.5 decimal or better.~* Other protocol-specified inclusion criteria may apply.~Key Exclusion Criteria:~* Irregular corneal astigmatism.~* History of anterior segment, posterior segment, or optic nerve pathology.~* History of previous intraocular or corneal (refractive or trauma related) surgery.~* Any other planned ocular surgical procedures including but not limited to limbal relaxing incision (LRI)/Astigmatic Keratotomy and laser assisted in situ keratomileusis (LASIK).~* Other protocol-defined exclusion criteria may apply.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PanOptix Toric Trifocal IOL (Type: EXPERIMENTAL): ACRYSOF IQ PanOptix Toric Trifocal IOL Model TFNT20 implanted in the capsular bag in the posterior chamber following cataract surgery. At least one eye will be implanted.

Based on this trial design, predict the completion outcome and termination type (if applicable).